Posts Tagged ‘anastasia hayes’
Sichenzia Ross Ference LLP Represents Sunshine Biopharma, Inc. in $5.0 Million Private Placement Priced At-the-Market
Sichenzia Ross Ference LLP Represents Lexaria Bioscience Corp. in $2.0 Million Public Offering
Sichenzia Ross Ference LLP Represents Spartan Capital Securities, LLC in $6.25 Million Registered Direct Offering of Common Stock of Processa Pharmaceuticals, Inc.
Sichenzia Ross Ference LLP Represents Verb Technology Company, Inc. in $7.2 Million Underwritten Public Offering of Common Stock
Press Release – New York, NY – January 26, 2023 – Sichenzia Ross Ference LLP announced today that it represented Verb Technology Company, Inc. (NASDAQ: VERB), the leader in interactive video-based sales-enablement applications, in a $7.2 Million Underwritten Public Offering of common stock. The offering consisted of 36,051,000 shares of common stock (the “Offering”) at a…
Read MoreSichenzia Ross Ference LLP Represents Murphy Canyon Acquisition Corp. in Definitive Merger Agreement with Conduit Pharmaceuticals Limited
Press Release – New York, NY November 9, 2022 – Sichenzia Ross Ference LLP announced today that it represented Murphy Canyon Acquisition Corp. (Nasdaq: MURF), a publicly traded special purpose acquisition company (SPAC) in a definitive merger agreement with Conduit Pharmaceuticals Limited (“Conduit”). The combined company is anticipated to have an implied initial enterprise value…
Read More
